Antibodies against Plasmodium falciparum erythrocyte membrane protein-1 that correlate with protection from severe malaria in children

Background Plasmodium falciparum erythrocyte membrane protein-1 (PfEMP1) are multidomain variant antigens on P. falciparum- infected erythrocytes (IE) that mediate vascular sequestration. Expression of specific PfEMP1 are upregulated in severe malaria (SM), and IgG against them has been linked to protection. The Fc features of PfEMP1-specific antibodies that correlate with protection from severe malaria are not well defined. A combination of PfEMP1 antibody targets and Fc features may distinguish between children with SM and UM. Methods We measured antibodies against 28 PfEMP1 antigen domains in Papua New Guinean children with SM (n = 141) or UM (n = 68), at presentation and eight weeks convalescence. We measured IgG, IgG subclasses, Fc receptor and C1q binding, and measured antibody dependent THP-1 cell and neutrophil phagocytosis (ADNP) of IEs. Results At presentation, UM was positively associated with IgG, IgG1, IgG3 and FcγRIII binding antibodies, against domains that bind endothelial protein C receptor (EPCR), intercellular adhesion molecule-1 (ICAM-1) or CD36, and with ADNP of IE that bind ICAM-1 and CD36 (two-fold difference in mean antibodies, p-value range 0.03 to 10 − 10 ). Associations were most notable when compared to children with severe anaemia. By convalescence, FcγRIIIb and FcγRIIb binding antibodies declined while C1q binding antibodies increased. Using Elastic Net Regression modelling, functional antibodies targeting diverse PfEMP1 domains distinguished between SM or UM with 84% accuracy (77–89%), whereas using only EPCR binging variants achieved 66% (57–74%). Using Tensor-structured decomposition, variation between SM and UM was driven by functional antibodies against all PfEMP1 domains. Conclusions IgG1 and IgG3 antibodies that engage Fc receptors and target EPCR, ICAM-1 and CD36 binding domains, and ADNP of IE, may protect from SM. Accurate classification of SM and UM requires functional antibody measures to a combination of PfEMP1 domains of multiple binding phenotypes, and deficiencies in antibodies vary between SM presentations. Interventions to prevent SM or biomarker panels to predict protective immunity may need to include a breadth of PfEMP1 variant targets.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11383498/v1
Primary Topic
Malaria Research and Control
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Antibodies against Plasmodium falciparum erythrocyte membrane protein-1 that correlate with protection from severe malaria in children

Eizo Takashima, Daniel Getacher Feleke, Aaron S. Meyer, Laurens A. Manning et al.
Research Square
Malaria Research and Control
preprint

Antibodies against Plasmodium falciparum erythrocyte membrane protein-1 that correlate with protection from severe malaria in children

Eizo Takashima, Daniel Getacher Feleke, Aaron S. Meyer, Laurens A. Manning, Louise Turner, Yvonne Adams, Moses Laman, Anja T. R. Jensen, Isobel S. Walker, Elvin Lufele, Thomas Lavstsen, Wina Hasang, Ivo Müeller, Timothy M. E. Davis, Stephen John Rogerson, Elizabeth H. Aitken, Janavi S. Rambhatla, Julie Anne Simpson, Takafumi Tsuboi, Michael F. Duffy, Amy W. Chung, J. Alexandra Rowe, Megha Rajasekhar, Rebecca W. Olsen, Ali Haghiri, Stanley E Otoboh, O. B. Williams, Amaya Ortega Pajares
preprint en

Abstract

Background Plasmodium falciparum erythrocyte membrane protein-1 (PfEMP1) are multidomain variant antigens on P. falciparum- infected erythrocytes (IE) that mediate vascular sequestration. Expression of specific PfEMP1 are upregulated in severe malaria (SM), and IgG against them has been linked to protection. The Fc features of PfEMP1-specific antibodies that correlate with protection from severe malaria are not well defined. A combination of PfEMP1 antibody targets and Fc features may distinguish between children with SM and UM. Methods We measured antibodies against 28 PfEMP1 antigen domains in Papua New Guinean children with SM (n = 141) or UM (n = 68), at presentation and eight weeks convalescence. We measured IgG, IgG subclasses, Fc receptor and C1q binding, and measured antibody dependent THP-1 cell and neutrophil phagocytosis (ADNP) of IEs. Results At presentation, UM was positively associated with IgG, IgG1, IgG3 and FcγRIII binding antibodies, against domains that bind endothelial protein C receptor (EPCR), intercellular adhesion molecule-1 (ICAM-1) or CD36, and with ADNP of IE that bind ICAM-1 and CD36 (two-fold difference in mean antibodies, p-value range 0.03 to 10 − 10 ). Associations were most notable when compared to children with severe anaemia. By convalescence, FcγRIIIb and FcγRIIb binding antibodies declined while C1q binding antibodies increased. Using Elastic Net Regression modelling, functional antibodies targeting diverse PfEMP1 domains distinguished between SM or UM with 84% accuracy (77–89%), whereas using only EPCR binging variants achieved 66% (57–74%). Using Tensor-structured decomposition, variation between SM and UM was driven by functional antibodies against all PfEMP1 domains. Conclusions IgG1 and IgG3 antibodies that engage Fc receptors and target EPCR, ICAM-1 and CD36 binding domains, and ADNP of IE, may protect from SM. Accurate classification of SM and UM requires functional antibody measures to a combination of PfEMP1 domains of multiple binding phenotypes, and deficiencies in antibodies vary between SM presentations. Interventions to prevent SM or biomarker panels to predict protective immunity may need to include a breadth of PfEMP1 variant targets.

Research Square
University of Copenhagen (DK), Burnet Institute (AU), The University of Melbourne (AU), The University of Western Australia (AU), Walter and Eliza Hall Institute of Medical Research (AU), Ehime University (JP), Massachusetts Institute of Technology (US), Papua New Guinea Institute of Medical Research (PG), University of Edinburgh (GB)
Malaria Research and Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon